In cell-mediated (ex vivo) gene therapy, retroviruses expressing the ADA gene are used for treating severe combined immunodeficiency (SCID) [17], and lentiviruses are utilized to deliver the ABCD1 gene for the treatment of adrenoleukodystrophy (ALD) [18]. The gene discussed is ADA; the disease is X-linked adrenoleukodystrophy.